Roland Fischer1, Carole Clair2, Joseph Studer3, Jacques Cornuz2, Gerhard Gmel4. 1. 1 Department for Ambulatory Care and Community Medicine, University of Lausanne, Switzerland Roland.Fischer@chuv.ch. 2. 1 Department for Ambulatory Care and Community Medicine, University of Lausanne, Switzerland. 3. 2 Alcohol Treatment Centre, Lausanne University Hospital CHUV, Switzerland. 4. 2 Alcohol Treatment Centre, Lausanne University Hospital CHUV, Switzerland3 Addiction Suisse, Lausanne, Switzerland.
Abstract
BACKGROUND: Smokeless tobacco is of increasing interest to public health researchers and policy makers. This study aims to measure prevalence of smokeless tobacco use (nasal dry snuff, snus and chewing tobacco) among young Swiss men, and to describe its correlates. METHODS: We invited 13 245 young men to participate in this survey on socio-economic and substance use data. Response rate was 45.2%. We included 5720 participants. Descriptive statistics and multivariable-adjusted logistic regression were performed. RESULTS: Mean age of participants was 19.5 years. Self-reported use once a month or more often was 8% for nasal dry snuff, 3% for snus and negligible for chewing tobacco. In multivariable-adjusted logistic regression, the odds for nasal dry snuff use increased in non daily smokers [odds ratio (OR) 2.41, 95% confidence interval (CI) 1.90-3.05], compared with non smokers, participants reporting risky weekly drinking volume (OR 3.93, 95% CI 1.86-8.32), compared with abstinents, and binge drinking once a month or more often (OR 7.41, 95% CI 4.11-13.38), compared with never binge drinking. Nasal dry snuff use was positively associated with higher BMI, average or above family income and German language, compared with French, and negatively associated with academic higher education, compared with non higher education, and occasional cannabis use, compared with no cannabis use. Correlates of snus were similar to those of nasal dry snuff. CONCLUSION: One in 12 young Swiss men use nasal dry snuff and 3% use snus. Consumption of smokeless tobacco is associated with a cluster of other risky behaviours, especially binge drinking.
BACKGROUND: Smokeless tobacco is of increasing interest to public health researchers and policy makers. This study aims to measure prevalence of smokeless tobacco use (nasal dry snuff, snus and chewing tobacco) among young Swiss men, and to describe its correlates. METHODS: We invited 13 245 young men to participate in this survey on socio-economic and substance use data. Response rate was 45.2%. We included 5720 participants. Descriptive statistics and multivariable-adjusted logistic regression were performed. RESULTS: Mean age of participants was 19.5 years. Self-reported use once a month or more often was 8% for nasal dry snuff, 3% for snus and negligible for chewing tobacco. In multivariable-adjusted logistic regression, the odds for nasal dry snuff use increased in non daily smokers [odds ratio (OR) 2.41, 95% confidence interval (CI) 1.90-3.05], compared with non smokers, participants reporting risky weekly drinking volume (OR 3.93, 95% CI 1.86-8.32), compared with abstinents, and binge drinking once a month or more often (OR 7.41, 95% CI 4.11-13.38), compared with never binge drinking. Nasal dry snuff use was positively associated with higher BMI, average or above family income and German language, compared with French, and negatively associated with academic higher education, compared with non higher education, and occasional cannabis use, compared with no cannabis use. Correlates of snus were similar to those of nasal dry snuff. CONCLUSION: One in 12 young Swiss men use nasal dry snuff and 3% use snus. Consumption of smokeless tobacco is associated with a cluster of other risky behaviours, especially binge drinking.
Authors: Stéphane Henninger; Roland Fischer; Jacques Cornuz; Joseph Studer; Gerhard Gmel Journal: Int J Environ Res Public Health Date: 2015-06-25 Impact factor: 3.390
Authors: Michael P Schaub; Andreas Wenger; Oliver Berg; Thilo Beck; Lars Stark; Eveline Buehler; Severin Haug Journal: J Med Internet Res Date: 2015-10-13 Impact factor: 5.428
Authors: Michael P Schaub; Severin Haug; Andreas Wenger; Oliver Berg; Robin Sullivan; Thilo Beck; Lars Stark Journal: BMC Psychiatry Date: 2013-11-14 Impact factor: 3.630
Authors: Manuel Amann; Severin Haug; Andreas Wenger; Christian Baumgartner; David D Ebert; Thomas Berger; Lars Stark; Marc Walter; Michael P Schaub Journal: JMIR Res Protoc Date: 2018-01-31